Virology Ran With It

Ask why so many people now doubt the official account behind a new outbreak, and the easy answer is that they've been radicalized by fringe belief. There's a harder, better-sourced answer that doesn't need any of that to make its case: virology's own published history gives more than enough reason on its own, starting on the day the field made its name.

1881 — The Founding Deception

In May 1881, at Pouilly-le-Fort, Louis Pasteur staged the most famous public demonstration in the history of medicine: vaccinated sheep survived an anthrax challenge, unvaccinated sheep died, in front of reporters and dignitaries. It made his name and, with it, the credibility of the entire vaccine enterprise that followed. Pasteur told the world the vaccine was made using his own method — attenuating the anthrax bacterium through exposure to atmospheric oxygen.

It wasn't. Historians Cadeddu (1987) and Gerald Geison — working from Pasteur's own private laboratory notebooks, sealed by his family until 1971 — found that the actual vaccine used at Pouilly-le-Fort was made with a chemical method (potassium bichromate) developed by a rival veterinarian, Jean-Joseph Henri Toussaint, who had visited Pasteur's lab and shown him the technique. Pasteur used it, gave no credit, and let the public believe it was his own. Geison's own words: "a clear case of scientific misconduct."

1885 — Before the Word Even Existed

Four years later, developing his rabies vaccine, Pasteur created the "fixed virus" — passaging the rabies agent serially through rabbit spinal cords to deliberately change its behavior, dialed toward safety for his vaccine. This is a genuinely striking fact, easy to check and rarely stated plainly: deliberate, directed manipulation of a pathogen's behavior is older than the scientific recognition that viruses exist. Dmitri Ivanovsky's 1892 discovery of the filterable tobacco mosaic agent — the moment usually cited as virology's birth — came seven years later. Martinus Beijerinck didn't coin the word "virus" in its modern sense until 1898, thirteen years after Pasteur was already doing this. Pasteur had no concept of a virus particle, no microscope capable of seeing one. He manipulated an agent whose physical nature he could not describe, purely through empirical technique.

The direction in 1885 was attenuation — weakening, for safety. But the core method is identical to what's controversial today: repeatedly pass a pathogen through an unnatural host or condition to deliberately change what it does. Modern gain-of-function research turns the same dial the other way.

Four Civilizations, One Blind Spot They Didn't Have

Long before anyone had a germ theory to argue about, independent medical traditions — with no contact with each other — converged on a different model of what makes a fever-with-eruption illness happen: not an external entity invading the body, but an internal state going wrong.

None of these traditions had microscopy. None of them could have described a virus particle. But they weren't wrong about everything — they were tracking a real variable that the germ-theory framework which followed would spend the next century minimizing: host terrain conditions the outcome. Modern immunology has since confirmed exactly that variable matters, just not in the way any single ancient tradition framed it. That reconciliation comes later in this piece.

1937 — The Rules Changed to Fit the Tool

Robert Koch's four postulates (1884) required, among other things, growing the suspected pathogen in pure culture. This works for bacteria on agar. It is biologically impossible for viruses, which are obligate intracellular parasites — they cannot replicate outside a living cell, full stop. That property is not incidental; it's the very thing that let Ivanovsky and Beijerinck recognize viruses as a distinct category in the first place, back in 1892.

Thomas Rivers, delivering the presidential address to the Society of American Bacteriologists in December 1936 (published in the Journal of Bacteriology, 1937), proposed revised criteria fitted to what could actually be shown for an intracellular parasite: the virus found with regularity in association with the disease, shown to occur in the sick individual, transmissible via a filtrate free of other organisms. One genuine loosening is worth naming honestly: Rivers no longer required the agent to be found in literally every case, allowing for the existence of asymptomatic carriers — a real, defensible biological adjustment, and also, structurally, a lower bar than Koch's original standard.

The point isn't that Rivers cheated. It's that for roughly six decades, the field's evidentiary standard was harder for outsiders to independently audit than the bacteriology it descended from — a gap only closed by tools that arrived generations later.

From Weakening to Strengthening — the Same Technique, Reversed

The serial-passage principle Pasteur used to attenuate rabies in 1885 ran through the entire 20th century of vaccine development — Sabin's polio strain, the Edmonston measles strain, all weakened the same way. Recombinant DNA technology (Cohen and Boyer, 1970s) changed what was possible: for the first time, researchers could cut and edit a genome directly, rather than waiting for passage to accidentally select the right mutation.

What followed is not speculation — it's the field's own published record. In 2011, Ron Fouchier's team (Erasmus Medical Center) and Yoshihiro Kawaoka's team (University of Wisconsin/University of Tokyo) separately engineered H5N1 avian flu to transmit between ferrets via the respiratory route — work published in Science (Fouchier, June 2012) and Nature (Kawaoka, May 2012) after a self-imposed research pause and public debate over whether it should be published at all, given that viruses transmissible between ferrets are frequently also transmissible between humans. It triggered a formal U.S. gain-of-function research moratorium in 2014.

In 2015, Vineet Menachery and Ralph Baric (UNC) published, in Nature Medicine, a chimeric virus built by inserting the spike protein of a bat coronavirus, SHC014, into a mouse-adapted SARS backbone — engineered specifically to test whether it could infect human airway cells using the human ACE2 receptor. It could, efficiently, at titers matching epidemic-strain SARS-CoV. The paper's own stated purpose: assessing pandemic potential and preparedness. This is the same technique family that began as Pasteur's rabbit-spinal-cord passage in 1885, run in the opposite direction, with tools he could not have imagined.

A Field Built to Reward Exactly This

None of the above requires believing any individual researcher set out to cause harm. It requires only recognizing what a discipline organized around characterizing and creating viral function structurally rewards: a virus made more capable is, within that field's own incentive structure, more publishable, more fundable, more "interesting" — regardless of any single scientist's intent. The same technical skill sitting inside immunology (built around host response) or molecular biology (virus as one object among many) would answer to a different set of institutional rewards. This is a structural critique, not an accusation against a person — the same kind of argument this publication has made before about consensus science generally: the mechanism is repeatable because it's built into incentives, not because anyone is uniquely dishonest.

What the Terrain Traditions Were Tracking All Along

Here is where the ancient framing and modern research actually meet. The Bandim Health Project, led by Peter Aaby in Guinea-Bissau since the 1980s, documented that vaccines carry effects on overall mortality beyond their single target disease — published in the BMJ in 1995 and confirmed in a randomized controlled trial in the BMJ in 2010. Some sequences appeared protective beyond their target; others did not. The WHO withdrew a high-titer measles vaccine after it was linked to increased female mortality — later traced specifically to children who received a standard DTP vaccine after the high-titer measles dose, a sequencing interaction, not a simple "vaccine causes harm" story. It's worth stating plainly that this remains a genuinely contested research area: a 2025 systematic review did not find support for non-specific effects from standard-titre measles vaccine specifically. The honest read is that host-immune-system interactions between interventions are real and published, not that any single finding here is settled.

Antibody-dependent enhancement is not contested in the same way. Sanofi's own 2017 disclosure — that its dengue vaccine Dengvaxia could increase the risk of severe disease in people never previously exposed to dengue — triggered a Philippine government mass-vaccination scandal (over 830,000 children vaccinated from 2016), a formal "causal association" finding by the Philippine Department of Health for pediatric deaths in 2018, and criminal indictments recommended against Sanofi and health officials in 2019. Sanofi halted production entirely in January 2024. This is not a theory. It is a proven, government-investigated case of a vaccine making a later, related infection more dangerous through immune interference — the exact mechanism the ancient traditions were gesturing at without the molecular vocabulary to name it: the internal terrain, once altered, changes what the next threat does to you.

Anticipating the Rebuttal

The strongest version of the pushback to everything above rarely disputes the sources directly — Pasteur's notebooks, Rivers' 1937 paper, the 2012 and 2015 GOF papers, and the Dengvaxia timeline are all a matter of public record. It disputes the interpretation. Six objections worth taking seriously, in the strongest form they're likely to arrive in:

The Audit, Not the Denial

Put the pieces in order: a founding public demonstration built on a hidden method (1881). A directed pathogen-manipulation technique that predates the scientific definition of a virus (1885). Four independent civilizations that, lacking microscopy, correctly identified internal terrain as a determining factor centuries before immunology could explain why (documented, above). An evidentiary standard rewritten specifically because the original one couldn't be met (1937), not closed by better tools for another sixty years. A field whose own incentive structure rewards building more capable pathogens (documented in its own journals, 2012 and 2015). And a genuine, government-prosecuted precedent for exactly the kind of immune interference this piece has been building toward the whole way (2016–2024).

None of that requires any belief system outside virology's own published record to explain today's skepticism. It's sitting in virology's own peer-reviewed literature, in order, since before the field had a name. This isn't an argument that viruses are fictional, and it isn't an argument that they're proven either — it's an argument that the field hasn't earned the authority to settle that question on its own say-so, and that the question belongs with the neighboring disciplines that don't share its incentive to keep finding more.